Monograph #098

Teasel

Dipsacus fullonum · Fuller's Teasel · Common Teasel · Wild Teasel
★★★☆☆ Evidence Bitter Tonic / Digestive Stimulation NF-κB / Anti-Inflammatory Root

Teasel root evidence base is dominated by traditional Chinese medicine research (for Dipsacus asper / Xu Duan) and Western herbal clinical use in Lyme disease protocols. Directly controlled human RCT evidence for D. fullonum specifically is limited. This section reflects the available evidence with appropriate qualification.

01 Identity 02 Compounds 03 Pathways 04 Biomarkers 05 Extraction 07 Dosing 08 Synergies 09 Safety 11 Evidence 12 Protocol

Botanical Profile

Dipsacus fullonum L. — Root (dried; primary medicinal part); Leaf (traditional); Seed head (ecological/craft use). Native to Europe, North Africa, and western Asia; widely naturalized across North America as a roadside and field biennial; now common throughout temperate North America

Root: bitter, slightly acrid, pungent; dense, fibrous cross-section with distinctive central channel in older roots; strong earthy-bitter aroma when cut fresh. Dried root: dark tan-brown, hard, fibrous. Taste: intensely bitter with earthy, woody undertones. The bitterness is characteristic and becomes important as a diagnostic indicator — authentic teasel root should be noticeably bitter. Water extracted from the leaf axis ('Venus' basin') was traditionally used as an eye wash and cosmetic.

Species Integrity

Dipsacus fullonum (wild teasel) and Dipsacus sativus (Fuller's teasel, with hooked bracts) are closely related and used interchangeably medicinally. Both are naturalized in North America. Dipsacus asper (Asian teasel, Xu Duan in Chinese medicine) is a distinct species with a more extensively documented clinical record in Chinese herbal medicine, but D. fullonum shares key active compounds and is the primary Western species.

Active Compound Profile

Iridoid glycosides (loganin, sweroside, sylvestroside, cantleyoside)
0.5–3% dry weight
Bitter tonic via bitter taste receptor (TAS2R) activation; anti-inflammatory via NF-κB and COX-2 inhibition; hepatoprotective; anti-cancer cytotoxicity in some cell lines; antimicrobial activity
Saikosaponins and triterpenoid saponins
Variable; present in root
Anti-inflammatory; immunomodulatory; liver protective; adaptogenic properties similar to other saponin-containing plants
Dipsacus saponins (astersaponins)
0.1–0.5%
Anti-osteoporotic activity (stimulates osteoblast proliferation, inhibits osteoclast differentiation); bone remodeling support
Alkaloids (including tryptamine derivatives)
Trace amounts
Antimicrobial; possible CNS modulating activity
Chlorogenic acid, caffeic acid, and polyphenols
0.5–1.5%
Antioxidant; anti-inflammatory; hepatoprotective; mild antimicrobial
Absorption

Tincture or decoction for iridoid glycoside extraction: Iridoid glycosides are water-soluble and ethanol-soluble; both decoction and tincture preparations effectively extract key active compounds; tincture provides greater consistency and shelf stability

Mechanism of Action

★★★☆☆ Bitter Tonic / Digestive Stimulation Iridoid glycosides (loganin, sweroside) activate TAS2R bitter taste receptors in the GI tract; trigger cephalic phase digestive secretion including gastric acid, bile, and pancreatic enzyme release; improve nutrient absorption and digestive efficiency
★★★☆☆ NF-κB / Anti-Inflammatory Iridoid glycosides and polyphenols inhibit NF-κB nuclear translocation; reduce TNF-α, IL-6, and COX-2; loganin and sylvestroside show specific anti-inflammatory activity in multiple in vitro models
★★★☆☆ Bone Remodeling / Osteogenesis Dipsacus saponins (astersaponins) stimulate osteoblast differentiation and proliferation (Wnt/β-catenin signaling); inhibit osteoclast differentiation (RANKL signaling); documented in multiple controlled in vitro and animal studies
★★★☆☆ Antimicrobial / Anti-Spirochetal Iridoids and alkaloids in teasel root have documented antimicrobial activity; Stephen Buhner's research and clinical observations suggest anti-spirochetal activity against Borrelia burgdorferi (Lyme disease); mechanism proposed involves disruption of spirochetal quorum sensing and biofilm formation
★★★☆☆ Hepatoprotection Iridoid glycosides demonstrate hepatoprotective activity in animal models; protect against chemically-induced hepatocellular damage; reduce liver enzyme elevation; anti-inflammatory effect in hepatic tissue

What It Moves in Your Labs

BiomarkerDirectionTargetMechanism
hs-CRP ↓ Decrease <1.0 mg/L Iridoid glycoside NF-κB inhibition reduces systemic inflammatory cytokine production
Liver Enzymes (ALT, AST) ↓ Decrease (if elevated) ALT <35 IU/L; AST <35 IU/L Hepatoprotective iridoids protect hepatocytes from inflammatory and oxidative damage; relevant if concurrent liver stress from medications or infections
Bone Density (DEXA) ↑ Improve T-score > -1.0 (within normal range) Dipsacus saponin stimulation of osteoblastogenesis via Wnt/β-catenin; RANKL inhibition of osteoclast differentiation
Joint Pain (VAS or WOMAC) ↓ Decrease Clinical improvement in joint pain scores NF-κB-mediated reduction of synovial inflammation; prostaglandin pathway modulation by iridoids

Extraction & Preparation

Tincture (1:5, 60% ethanol): Full iridoid glycoside extraction; saponins and polyphenols included

Solubility · Water-soluble as glycosides; also ethanol-solubleMenstruum · 60% ethanolPlant material · Dried Dipsacus fullonum root, cut or powderedMaceration time · 4–6 weeks (agitate daily)Ratio · 1:5 (dried)

Dosing Framework

Anti-inflammatory/Lyme protocol: take 3 doses spread throughout the day; with meals to reduce any GI discomfort from bitter compounds; morning, midday, evening timing.

Dose 1
Therapeutic (anti-inflammatory, Lyme protocol): 3–5 mL tincture, 3x daily
Buhner protocol dose; 4–6 month minimum duration for Lyme applications; monitor response
Dose 3
Digestive bitters: 10–20 drops tincture, 10–15 minutes pre-meal
Sub-therapeutic anti-inflammatory dose; purely bitter tonic application; combine with other bitters (gentian, dandelion) for full formula

Synergy Partners

★★★☆☆ Japanese Knotweed (Polygonum cuspidatum / resveratrol) Core Buhner Lyme protocol combination; knotweed's resveratrol provides NF-κB inhibition, SIRT1 activation, and potential anti-spirochetal activity via different mechanisms than teasel's iridoids; combined provides broader anti-inflammatory and anti-microbial coverage
★★★☆☆ Cat's Claw (Uncaria tomentosa) Oxindole alkaloids in cat's claw modulate T-cell and NK cell activity; immunomodulatory complementary to teasel's anti-inflammatory iridoids; combined addresses both immune dysfunction and inflammation in Lyme-Hashimoto's overlap
★★★☆☆ Boswellia (Boswellia serrata) AKBA (Boswellic acid) specifically inhibits 5-LOX and leukotriene B4 synthesis; teasel's iridoids inhibit COX-2 and NF-κB; combined covers both leukotriene and prostaglandin inflammatory pathways comprehensively
★★★☆☆ Gentian (Gentiana lutea) Gentian's secoiridoid bitters (gentiopicroside) are more potent bitter taste receptor activators than teasel's iridoids; combined digestive bitters formula provides more complete bitter tonic effect
Signature Stack

THE LYME-HASHIMOTO OVERLAP PROTOCOL
Components: Teasel Root (Dipsacus fullonum) + Japanese Knotweed (Polygonum cuspidatum) + Cat's Claw (Uncaria tomentosa) + Astragalus (Astragalus membranaceus) · Multi-pathway convergence: Anti-spirochetal / antimicrobial (teasel + knotweed + cat's claw) + NF-κB inhibition (knotweed resveratrol + teasel iridoids) + immune normalization (cat's claw + astragalus) + HPA adaptogenic support (astragalus) · Borrelia burgdorferi infection is documented as a significant trigger and perpetuator of autoimmune thyroid disease, including Hashimoto's. This stack addresses the Lyme-Hashimoto overlap that is clinically common but rarely recognized in conventional medicine. The herbs address both the potential microbial trigger and the resulting autoimmune inflammatory response. · Practical integration: Joint Support Tincture Blend (teasel + knotweed + cat's claw) taken 3x daily; astragalus decoction or tincture separately in morning protocol; work with a Lyme-literate integrative practitioner to determine if Lyme testing and protocol is indicated.

Contraindications & Interactions

Avoid Pregnancy Iridoid glycosides from teasel have theoretical uterotonic activity at high doses; traditional emmenagogue use of related Dipsacaceae plants documented. Insufficient safety data for pregnancy.
Minor Hypoglycemia / antidiabetic medications Iridoids from Dipsacus species have hypoglycemic activity in animal models; may potentiate insulin and antidiabetic medication effects.
Minor Bitter intolerance / GI sensitivity Therapeutic doses of iridoid-rich teasel root may cause nausea, GI cramping, or diarrhea in bitter-sensitive individuals.

Evidence Base

★★★☆☆ Anti-Inflammatory (Iridoid Mechanism) Moderate — Strong mechanistic + in vitro/animal evidence; limited human RCTs
★★★☆☆ Bone Healing / Anti-Osteoporotic (D. asper / Xu Duan) Moderate — Multiple controlled animal studies + small human trials; primarily D. asper research
★☆☆☆☆ Anti-Spirochetal / Lyme Disease Support Preliminary — Clinical observation and theoretical; no controlled human RCT
★★★☆☆ Digestive Bitter Tonic Moderate — Mechanism well-established for iridoid bitters class; extensive traditional use
★★☆☆☆ Hepatoprotection Preliminary — Animal model evidence; limited human data

Evidence Gaps

The highest-value research gap for Meridian Medica: no human RCT has evaluated teasel root specifically for Hashimoto's thyroiditis or Lyme-associated autoimmune thyroid disease. A controlled pilot study evaluating teasel root tincture in Hashimoto's patients with confirmed or suspected Borrelia co-infection (measuring TPO antibodies, inflammatory markers, and Borrelia serology) would be a unique contribution to both integrative Lyme medicine and autoimmune thyroid disease management. Additionally, direct in vitro anti-Borrelia testing of D. fullonum specifically (rather than generic antimicrobial claims) would strengthen or refute the Buhner protocol scientific basis.

Quality Alert

Teasel root adulteration risk has increased with the Lyme disease herbal protocol market:

Protocol Integration

Layer 1: Hypothalamic / Autonomic — HPA axis, circadian rhythm, stress response

Layer 2: Systemic Nutritional Repletion — Micronutrient optimization, antioxidant defense

Layer 3: Gut Permeability / Microbiome — Tight junction repair, motility, SIBO management

Recipe Integration
Joint Support Tincture Blend (signature preparation)
3–5 mL, 3x daily with meals
Feed the Markers

Teasel Root appears in the following Meridian Medica protocol contexts: